Cogent Biosciences, Inc. Earnings Per Share (Basic)
Cogent Biosciences, Inc. (COGT) reported Earnings Per Share (Basic) of -$0.52 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Cogent Biosciences, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.52.
- Cogent Biosciences, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.53.
- Cogent Biosciences, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.50.
- Cogent Biosciences, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.53.
- Cogent Biosciences, Inc. earnings per share, basic for fiscal 2025 was -$2.16.
- Cogent Biosciences, Inc. earnings per share, basic for fiscal 2024 was -$1.94.
- Cogent Biosciences, Inc. earnings per share, basic for fiscal 2023 was -$1.94.
- Cogent Biosciences, Inc. earnings per share, basic for fiscal 2022 was -$1.73.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.52 10-Q · filed 2026-08-10 | -$1.05 10-Q · filed 2026-08-10 | ||||||
| 2026-03-31 | -$0.53 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | -$2.16 10-K · filed 2026-02-17 | |||||||
| 2025-09-30 | -$0.50 10-Q · filed 2025-11-07 | -$1.55 10-Q · filed 2025-11-07 | ||||||
| 2025-06-30 | -$0.53 10-Q · filed 2026-08-10 | -$1.05 10-Q · filed 2026-08-10 | ||||||
| 2025-03-31 | -$0.52 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | -$1.94 10-K · filed 2026-02-17 | |||||||
| 2024-09-30 | -$0.52 10-Q · filed 2025-11-07 | -$0.64 10-Q · filed 2024-11-12 | -$1.24 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$1.44 10-Q · filed 2025-11-07 | -$1.85 10-Q · filed 2024-11-12 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-02-17 | ||
| 2024-06-30 | -$0.43 10-Q · filed 2025-08-05 | -$0.59 10-Q · filed 2024-08-06 | -$0.91 10-Q · filed 2025-08-05 | -$1.21 10-Q · filed 2024-08-06 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-02-17 | -$2.47 derived: net income ÷ weighted average shares · filed 2026-02-17 | ||
| 2024-03-31 | -$0.49 10-Q · filed 2025-05-06 | -$0.62 10-Q · filed 2024-05-07 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-02-17 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-02-17 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-02-17 | |||
| 2023-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-02-17 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-02-17 | -$1.86 derived: net income ÷ weighted average shares · filed 2026-02-17 | -$1.94 10-K · filed 2026-02-17 | -$2.42 10-K · filed 2024-02-26 | |||
| 2023-09-30 | -$0.64 10-Q · filed 2024-11-12 | -$1.24 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.79 10-Q · filed 2024-11-12 | -$2.35 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||||
| 2023-06-30 | -$0.59 10-Q · filed 2024-08-06 | -$1.14 10-Q · filed 2024-08-06 | -$1.70 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$2.20 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||||
| 2023-03-31 | -$0.55 10-Q · filed 2024-05-07 | -$1.11 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$1.61 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$2.28 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||||
| 2022-12-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$1.07 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$1.73 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$1.73 10-K · filed 2025-02-25 | -$2.39 10-K · filed 2023-03-14 | |||
| 2022-09-30 | -$0.50 10-Q · filed 2023-11-07 | -$1.18 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.84 10-Q · filed 2023-11-07 | -$2.44 derived: net income ÷ weighted average shares · filed 2024-02-26 | ||||
| 2022-06-30 | -$0.71 10-Q · filed 2023-08-08 | -$1.39 10-Q · filed 2023-08-08 | -$1.99 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$2.49 derived: net income ÷ weighted average shares · filed 2024-02-26 | ||||
| 2022-03-31 | -$0.68 10-Q · filed 2023-05-09 | -$1.28 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$1.77 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$2.21 derived: net income ÷ weighted average shares · filed 2024-02-26 | ||||
| 2021-12-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$1.08 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$1.51 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$1.87 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | -$0.48 10-Q · filed 2022-11-14 | -$0.91 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.25 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.43 10-Q · filed 2022-08-09 | -$0.77 10-Q · filed 2022-08-09 | ||||||
| 2019-12-31 | $0.07 10-K · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-03-16 | ||||
| 2019-09-30 | -$0.39 10-K · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-11-09 | ||||
| 2019-06-30 | -$0.34 10-K · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||||
| 2019-03-31 | -$0.39 10-K · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||||
| 2018-12-31 | -$0.29 10-K · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||||
| 2018-09-30 | -$0.34 10-K · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | |||||
| 2018-06-30 | -$0.31 10-K · filed 2020-03-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||||||
| 2018-03-31 | -$0.66 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |